These and other studies are indicative of ERK promotion of resistance to apoptosis; BVR itself has been shown to contribute to resistance to chemically-induced cell death, whether in the context of cancer therapy or oxidative stress inducing compounds such as arsenite (Miralem et al., 2005). This evidence concerns the gene MAPK1 and cancer.